Drug safety has a paperwork problem with human consequences. RxLogix is betting that connecting the work matters as much as automating it.
A medicine’s success can bury its maker in safety reports. Qinecsa has bought and built a business around getting those reports into useful shape - and giving specialists more time to read the warning signs.
3Analytics is building the quiet machinery behind safer drugs and devices - software that reads the literature, watches for warning signals and helps regulated teams act before a data problem becomes a patient problem.
Distributed Spectrum builds AI-powered radio-frequency sensors and software that automatically detect, classify, and locate signals - drones, jammers, tactical radios, GPS spoofers - in real time. Founded by three Harvard engineers, the company packs commercial hardware and edge AI into sub-one-pound sensors that give soldiers and analysts persistent spectrum awareness without specialist RF expertise. It raised a $25M Series A in March 2025 and has fielded systems with US military branches and partners in Ukraine.